|
ImmunoCAP
specific IgE blood testing provides objective, quantifiable
evidence of IgE-mediated allergen sensitivity to help the
clinician diagnose and manage common lower respiratory illnesses.
ImmunoCAP testing makes it relatively easy for primary care
clinicians to perform an allergy evaluation.1
Utilizing pre-selected profiles of both seasonal and inhalant
airborne allergens, ImmunoCAP test results provide the clinician
with clear evidence to help rule in or out the presence of
atopy, identify and quantify any specific allergic sensitivities,
and guide effective management (including avoidance counseling,
medication selection, immunotherapy, and timely referral).
When the results are negative, the clinician can focus on other
evaluations in order to probe for possible non-allergic triggers.
In patients with suspected asthma, allergy testing may be
conducted along with pulmonary function tests and other diagnostic
evaluations.2
ImmunoCAP testing can be conducted on patients of any age,
as young as 3 months, regardless of the medications they are
already taking, and only a single blood draw is required. Many
laboratories offer ImmunoCAP
testing.
|
